bepmed |

20150051636
l 2015
KR

10101. COMPOSITIONS OF MATRIX FOR NANO-POROUS PARTICLE USING HIGH PRESSURE SHIFT FREEZING PROCESS AND METHOD FOR PREPARATION THEREOF

Abstract

The present invention relates to a matrix structure having nanoporous particles, which is prepared by ultra high pressure shift freezing of a mixture of hydrophilic...

13:42 / methods / thereof

20150051495
l 2015
KR

10102. BIOARTIFICIAL IMMUNOGEN-REDUCED PORCINE HEPATIC LOBE BIOSCAFFORD AND METHOD FOR PREPARING THE SAME

Abstract

The present invention relates to a bio-artificial immunogen-removed pig mesenchymal bio scaffold and a method for preparing the same. Pig mesenchymal bio scaffolds according to...

13:42 / rest

104694542
l 2015
CN

10103. Micro RNA for accelerating tissue-engineered bone vascularization and application thereof

Abstract

The invention discloses micro RNA for accelerating tissue-engineered bone vascularization and application thereof and belongs to the technical field of gene engineering. The micro RNA...

13:42 / growth factors / methods

104694555
l 2015
CN

10104. Cloning method of Nanjiang yellow goat GSK-3beta gene coding region complete sequence

Abstract

The invention belongs to the technical field of animal gene engineering, and specifically relates to a cloning method of Nanjiang yellow goat GSK-3beta gene coding...

13:42 / cells / methods

2015175717
l 2015
US

10105. Hyaluronic Acid Derivative, Method of Preparation Thereof, Method of Modification Thereof and Use Thereof

Abstract

The invention relates to the preparation and use of α,β-unsaturated aldehyde of hyaluronan having a double bond in the positions 4 and 5 and an...

13:42 / methods / thereof

104694454
l 2015
CN

10106. Micro-carrier for cell culture as well as preparation method and application of micro-carrier

Abstract

The invention relates to a micro-carrier for cell culture as well as a preparation method and application of the micro-carrier. The carrier comprises positive charge...

13:42 / cells / methods

104689368
l 2015
CN

10107. Degradable three-dimensional porous magnesium-based biomaterial and preparation method thereof

Abstract

The invention discloses a degradable three-dimensional porous magnesium-based biomaterial and a preparation method thereof. The porous magnesium and magnesium alloy materials are in a three-dimensional...

13:42 / Biomaterial / Scaffolds

104684540
l 2015
CN

10108. Encapsulation of immiscible phases in silk fibroin biomaterials

Abstract

Embodiments of various aspects described herein relates to compositions and methods for encapsulation and/or stabilization of oil, lipid, hydrophobic and/or lipophilic compounds in a silk-based...

13:42 / methods / Scaffolds

104684575
l 2015
CN

10109. Vesicles which include epidermal growth factor and compositions that contain same

Abstract

The invention relates to vesicles which include epidermal growth factor (EGF), a cationic surface-active agent, and cholesterol or the derivatives thereof. The invention also discloses...

13:42 / growth factors / methods

104674454
l 2015
CN

10110. Method for manufacturing three-dimensional porous disorder scaffolds from polylactic acid molten spinning fibers by means of thermal bonding and solidifying

Abstract

The invention discloses a method for manufacturing three-dimensional porous disorder scaffolds from polylactic acid molten spinning fibers by means of thermal bonding and solidifying. The...

13:42 / methods / Scaffolds

Author: admin

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract